Document text
Principal Investigator: Alexander Minchev Tsankov
Organization: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Fiscal Year: 2021
Award: $839,491
Funding agency: National Heart Lung and Blood Institute
PROJECT SUMMARY
The new coronavirus (SARS-CoV-2) and associated disease (COVID-19) is a global threat to worldwide
economies and public health due to its highly contagious nature and rapid spread. To develop optimal
strategies for treatment of COVID-19, it is critical to understand the cell types and molecular mechanisms that
mediate coronavirus infection, tissue propagation, and host immune response. As recently reported, both
SARS-CoV and SARS-CoV-2 use the host ACE2 receptor protein and protease TMPRSS2 to gain cellular
entry. High-throughput single-cell RNA-sequencing (scRNA-seq) and Assay for Transposase-Accessible
Chromatin (scATAC-seq) now allow us to interrogate cell types and cell states at unprecedented resolution,
which has led to groundbreaking discoveries in lung tissue biology, including our lab’s and the Human Cell
Atlas recent survey of nasal and lung epithelial cell types that co-express ACE2 and TMPRSS2 consistent with
disease phenotype. It has been reported that individuals suffering from chronic respiratory diseases are more
susceptible to COVID-19 severe disease. We propose to leverage our expertise in lung biology, single-cell
analysis, and unique access to lung tissue at Mount Sinai from COVID-19 patients with chronic respiratory
disease comorbidities to define the cell types and regulatory mechanisms that mediate COVID-19 disease
susceptibility due to SARS-CoV-2 infection, propagation and interplay with the host immune response.
Towards this goal, we will perform scRNA-seq, scATAC-seq, and spatial transcriptomic sequencing of multiple
infected and non-infected lung regions in 25-30 patients with COVID-19 and chronic obstructive pulmonary
disease comorbidity following autopsy. The single-cell resolution data will allow us to characterize the
repertoire of SARS-CoV-2 infected cell and surrounding stromal and immune microenvironment and how they
contribute to developing COVID-19 severe disease. Analysis of scATAC-seq data from matched lung regions
will identify the key transcription factors and regulatory mechanisms driving the expression programs related to
viral infection, host immune response, and severe disease susceptibility. Finally, integration of ligand-receptor
pair expression and spatial transcriptomics information will elucidate at greater resolution and scale how cell-
cell interactions and tissue pathology are altered after coronavirus infection. Single-cell characterization of the
cell types, immune response, and regulatory mechanisms of infection will improve our understanding of virus-
host interactions and COVID-19 severe disease susceptibility in patients with chronic respiratory disease. This
will, in turn, provide mechanistic insight towards discovering new therapeutic targets that specifically benefit
COVID-19 patients with pre-existing respiratory conditions.
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><ACE2><Angiotensin Receptor><Antibodies><Antibody Diversity><Assay><Atlases><Automobile Driving><Autopsy><Basal Transcription Factor><Basal transcription factor genes><Bioassay><Biologic Assays><Biological Assay><Biology><Body Tissues><COPD><COVID crisis><COVID epidemic><COVID infected patient><COVID pandemic><COVID patient><COVID positive patient><COVID-19><COVID-19 crisis><COVID-19 epidemic><COVID-19 genome><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 infected patient><COVID-19 infection><COVID-19 pandemic><COVID-19 patient><COVID-19 positive patient><COVID-19 predisposition><COVID-19 public health crisis><COVID-19 susceptibility><COVID-19 therapy><COVID-19 treatment><COVID-19 virus><COVID-19 virus genome><COVID-19 vulnerability><COVID19><COVID19 crisis><COVID19 epidemic><COVID19 genome><COVID19 global health crisis><COVID19 global pandemic><COVID19 health crisis><COVID19 infection><COVID19 pandemic><COVID19 patient><COVID19 positive patient><COVID19 public health crisis><COVID19 therapy><COVID19 treatment><COVID19 virus><COVID19 virus genome><CV-19><CV19><Cell Body><Cell Communication><Cell Interaction><Cell-to-Cell Interaction><Cells><Cellular Assay><Chromatin><Chronic><Chronic Obstruction Pulmonary Disease><Chronic Obstructive Airway Disease><Chronic Obstructive Lung Disease><Chronic Obstructive Pulmonary Disease><CoV emergence><CoV-2><CoV2><Collaborations><Collection><Complementary DNA><Computer Analysis><Computer Models><Computerized Models><Coronaviridae><Coronaviridae Infections><Coronavirus><Coronavirus Infections><Coronavirus disease 2019 predisposition><Coronavirus disease 2019 susceptibility><Coronavirus disease 2019 vulnerability><Data><Diathesis><Disease><Disease susceptibility><Disorder><Distal><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Epithelial Cells><Epitheliasin Gene><Esteroproteases><Gene Expression><Gene Transcription><General Transcription Factor Gene><General Transcription Factors><Genetic Diversity><Genetic Transcription><Genetic Variation><Genomics><Goals><HCoV><Histologic><Histologically><Human><Immune><Immune response><Immune system><Immunes><Immunological response><Incidence><Individual><Infection><Isoforms><Ligands><Link><Location><Lung><Lung Parenchyma><Lung Respiratory System><Lung Tissue><Lung diseases><MHC Receptor><Major Histocompatibility Complex Receptor><Measurement><Mediating><Mediator><Mediator of Activation><Mediator of activation protein><Modern Man><Molecular><Nasal><Nasal Passages Nose><Nature><Non-Polyadenylated RNA><Nose><Nucleic Acid Regulator Regions><Nucleic Acid Regulatory Sequences><Nucleotides><Organ><Other Genetics><PRSS10><Pathology><Pathway interactions><Patients><Pattern><Peptidases><Peptide Hydrolases><Position><Positioning Attribute><Predisposed to COVID-19><Predisposed to SARS-CoV-2><Predisposed to Severe acute respiratory syndrome coronavirus 2><Protease Gene><Proteases><Protein Isoforms><Proteinases><Proteolytic Enzymes><Public Health><Pulmonary Diseases><Pulmonary Disorder><RNA><RNA Expression><RNA Gene Products><Receptor Protein><Receptors, Antigen, T-Cell><Regulation><Regulator Genes><Regulatory Regions><Reporting><Research><Resolution><Respiratory Disease><Respiratory System Disease><Respiratory System Disorder><Respiratory System, Nose, Nasal Passages><Ribonucleic Acid><SARS Virus><SARS corona virus><SARS corona virus 2><SARS coronavirus><SARS-Associated Coronavirus><SARS-CoV><SARS-CoV-2><SARS-CoV-2 epidemic><SARS-CoV-2 genome><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 infected patient><SARS-CoV-2 infection><SARS-CoV-2 pandemic><SARS-CoV-2 patient><SARS-CoV-2 positive patient><SARS-CoV-2 predisposition><SARS-CoV-2 susceptibility><SARS-CoV-2 therapy><SARS-CoV-2 treatment><SARS-CoV-2 vulnerability><SARS-CoV2><SARS-CoV2 epidemic><SARS-CoV2 genome><SARS-CoV2 infection><SARS-CoV2 pandemic><SARS-Related Coronavirus><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Sampling><Serine Endopeptidases><Serine Protease><Serine Protein Hydrolases><Serine Proteinases><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe Acute Respiratory Syndrome Virus><Severe Acute Respiratory Syndrome corona virus><Severe Acute Respiratory Syndrome coronavirus><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 infection><Severe acute respiratory syndrome coronavirus 2 pandemic><Severe acute respiratory syndrome coronavirus 2 predisposition><Severe acute respiratory syndrome coronavirus 2 susceptibility><Severe acute respiratory syndrome coronavirus 2 vulnerability><Severe acute respiratory syndrome related corona virus 2><Severities><Structure of parenchyma of lung><Surface><Survey Instrument><Surveys><T-Cell Receptor><TMPRSS2><TMPRSS2 gene><Technology><Tissues><Transcript><Transcription><Transcription Factor Proto-Oncogene><Transcription factor genes><Transcriptional Regulatory Elements><Transposase><Treatment Protocols><Treatment Regimen><Treatment Schedule><United States><Viral><Viral Diseases><Virus><Virus Diseases><Wuhan coronavirus><allergic/immunologic body system><allergic/immunologic organ system><angiotensin converting enzyme 2><angiotensin converting enzyme II><cDNA><cell assay><cell type><co-infection><co-morbid><co-morbidity><cohort><coinfection><comorbidity><computational analyses><computational analysis><computational modeling><computational models><computer analyses><computer based models><computerized modeling><corona virus><corona virus disease 2019><corona virus disease 2019 epidemic><corona virus disease 2019 pandemic><corona virus emergence><coronavirus disease 2019><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 genome><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 infected patient><coronavirus disease 2019 infection><coronavirus disease 2019 pandemic><coronavirus disease 2019 patient><coronavirus disease 2019 positive patient><coronavirus disease 2019 public health crisis><coronavirus disease 2019 therapy><coronavirus disease 2019 treatment><coronavirus disease 2019 virus><coronavirus disease 2019 virus genome><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease infected patient><coronavirus disease pandemic><coronavirus disease patient><coronavirus disease positive patient><coronavirus emergence><coronavirus patient><cytokine><data integration><disease of the lung><disease phenotype><disorder of the lung><driving><emergent CoV><emergent corona virus><emergent coronavirus><emerging CoV><emerging corona virus><emerging coronavirus><entire genome><full genome><genetic profiling><genetic regulatory element><hCoV19><high risk><host response><human CoV><human corona virus><human coronavirus><immune microenvironment><immune system response><immunoresponse><immunosuppressive microenvironment><immunosuppressive tumor microenvironment><improved><infected with COVID-19><infected with COVID19><infected with SARS-CoV-2><infected with SARS-CoV2><infected with coronavirus disease 2019><infected with severe acute respiratory syndrome coronavirus 2><insight><liability to disease><life-threatening COVID><life-threatening COVID-19><life-threatening SARS-CoV-2><life-threatening coronavirus disease><life-threatening coronavirus disease 2019><life-threatening severe acute respiratory syndrome coronavirus 2><lung disorder><nCoV><nCoV2><necropsy><new CoV><new corona virus><new coronavirus><new drug target><new drug treatments><new druggable target><new drugs><new pharmacotherapy target><new therapeutic target><new therapeutics><new therapy><new therapy target><next generation therapeutics><novel CoV><novel corona virus><novel coronavirus><novel drug target><novel drug treatments><novel druggable target><novel drugs><novel pharmacotherapy target><novel therapeutic target><novel therapeutics><novel therapy><novel therapy target><pathway><patient infected with COVID><patient infected with COVID-19><patient infected with SARS-CoV-2><patient infected with coronavirus disease><patient infected with coronavirus disease 2019><patient infected with severe acute respiratory syndrome coronavirus 2><patient with COVID><patient with COVID-19><patient with COVID19><patient with SARS-CoV-2><patient with coronavirus disease><patient with coronavirus disease 2019><patient with severe acute respiratory distress syndrome coronavirus 2><postmortem><predisposed to Coronavirus disease 2019><programs><pulmonary><receptor><recruit><regulatory gene><respiratory><response><scRNA-seq><serious COVID><serious COVID-19><serious SARS-CoV-2><serious coronavirus disease><serious coronavirus disease 2019><serious severe acute respiratory syndrome coronavirus 2><severe COVID><severe COVID-19><severe COVID19><severe SARS-CoV-2><severe acute respiratory syndrome coronavirus 2 genome><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><severe acute respiratory syndrome coronavirus 2 infected patient><severe acute respiratory syndrome coronavirus 2 patient><severe acute respiratory syndrome coronavirus 2 positive patient><severe acute respiratory syndrome coronavirus 2 therapy><severe acute respiratory syndrome coronavirus 2 treatment><severe acute respiratory syndrome-CoV><severe coronavirus disease><severe coronavirus disease 19><severe coronavirus disease 2019><severe severe acute respiratory syndrome coronavirus 2><single cell RNA-seq><single cell RNAseq><single cell analysis><single-cell RNA sequencing><susceptible to COVID-19><susceptible to Coronavirus disease 2019><susceptible to SARS-CoV-2><susceptible to Severe acute respiratory syndrome coronavirus 2><trans acting element><transcription factor><transcriptomics><treat COVID-19><treat COVID19><treat SARS-CoV-2><treat coronavirus disease 2019><treat severe acute respiratory syndrome coronavirus 2><treatment strategy><tumor immune microenvironment><tumor-immune system interactions><viral infection><virus host interaction><virus infection><virus-induced disease><whole genome>